Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma
Clinical trial NCT01456104 · COMPLETED
Trial details
- NCT number
- NCT01456104
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-17
- Primary completion
- 2023-01-12
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.